BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34674573)

  • 21. Comprehensive analysis of lymph nodes metastasis associated genes in cervical cancer and its significance in treatment and prognosis.
    Yang P; Ruan Y; Yan Z; Gao Y; Yang H; Wang S
    BMC Cancer; 2021 Nov; 21(1):1230. PubMed ID: 34789197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Construction of an immune-related gene signature for prediction of prognosis in patients with cervical cancer.
    Mei J; Xing Y; Lv J; Gu D; Pan J; Zhang Y; Liu J
    Int Immunopharmacol; 2020 Nov; 88():106882. PubMed ID: 32799114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening and identification of angiogenesis-related genes as potential novel prognostic biomarkers of hepatocellular carcinoma through bioinformatics analysis.
    Zhen Z; Shen Z; Hu Y; Sun P
    Aging (Albany NY); 2021 Jul; 13(13):17707-17733. PubMed ID: 34252885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of a novel six-gene signature with potential prognostic and therapeutic value in cervical cancer.
    Qu X; Shi Z; Guo J; Guo C; Qiu J; Hua K
    Cancer Med; 2021 Oct; 10(19):6881-6896. PubMed ID: 34498424
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatic Analysis to Identify a Multi-mRNA Signature for the Prediction of Metastasis in Hepatocellular Carcinoma.
    Liu L; Wang B; Han Q; Zhen C; Li J; Qu X; Wang F; Kong X; Zheng L
    DNA Cell Biol; 2020 Nov; 39(11):2028-2039. PubMed ID: 33147069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A multi-omics-based investigation of the prognostic and immunological impact of necroptosis-related mRNA in patients with cervical squamous carcinoma and adenocarcinoma.
    Zou J; Lin Z; Jiao W; Chen J; Lin L; Zhang F; Zhang X; Zhao J
    Sci Rep; 2022 Oct; 12(1):16773. PubMed ID: 36202899
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.
    Liu Z; Mi M; Li X; Zheng X; Wu G; Zhang L
    J Cell Mol Med; 2020 Nov; 24(21):12444-12456. PubMed ID: 32967061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
    Liu J; Lu J; Li W
    Front Immunol; 2021; 12():738068. PubMed ID: 34630418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer.
    Hu W; Li M; Zhang Q; Liu C; Wang X; Li J; Qiu S; Li L
    J Ovarian Res; 2021 Aug; 14(1):103. PubMed ID: 34364397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a RNA-seq-based signature to improve prognostics for uterine sarcoma.
    Zhou JG; Zhao HT; Jin SH; Tian X; Ma H
    Gynecol Oncol; 2019 Dec; 155(3):499-507. PubMed ID: 31662204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a nomogram based on long non-coding RNA to improve prognosis prediction of esophageal squamous cell carcinoma.
    Li W; Liu J; Zhao H
    Aging (Albany NY); 2020 Jan; 12(2):1512-1526. PubMed ID: 31978896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
    Li J; Li X; Zhang C; Zhang C; Wang H
    Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and validation of a potent multi-mRNA signature for the prediction of early relapse in hepatocellular carcinoma.
    Cai J; Tong Y; Huang L; Xia L; Guo H; Wu H; Kong X; Xia Q
    Carcinogenesis; 2019 Jul; 40(7):840-852. PubMed ID: 31059567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A five-mRNA signature associated with post-translational modifications can better predict recurrence and survival in cervical cancer.
    Ju M; Qi A; Bi J; Zhao L; Jiang L; Zhang Q; Wei Q; Guan Q; Li X; Wang L; Wei M; Zhao L
    J Cell Mol Med; 2020 Jun; 24(11):6283-6297. PubMed ID: 32306508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of a novel 10 immune-related genes signature as a prognostic biomarker panel for gastric cancer.
    Chen T; Yang C; Dou R; Xiong B
    Cancer Med; 2021 Sep; 10(18):6546-6560. PubMed ID: 34382341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
    Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
    J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer.
    Qi X; Fu Y; Zhang M; Lu C; Wang Y; Peng J; Li G
    Biomed Res Int; 2020; 2020():8882576. PubMed ID: 33224983
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel ferroptosis-related gene signature for predicting outcomes in cervical cancer.
    Qi X; Fu Y; Sheng J; Zhang M; Zhang M; Wang Y; Li G
    Bioengineered; 2021 Dec; 12(1):1813-1825. PubMed ID: 33989111
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
    Zou X; Hu Z; Huang C; Chang J
    Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrence-associated gene signature optimizes recurrence-free survival prediction of colorectal cancer.
    Tian X; Zhu X; Yan T; Yu C; Shen C; Hu Y; Hong J; Chen H; Fang JY
    Mol Oncol; 2017 Nov; 11(11):1544-1560. PubMed ID: 28796930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.